Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A 'tour de force' for clinical pharmacologists

David M. Burger; Joop E. Arends; Birgit S. Jacobs; Danielle H. M. van Elst-Laurijsen; Clara T. M. M. de Kanter; Erik van Maarseveen; Corrien P. W. G. M. Verwey-van Wissen; Andy I. M. Hoepelman

doi:10.1016/j.ijantimicag.2014.04.004

Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A 'tour de force' for clinical pharmacologists

David M. Burger^*, Joop E. Arends, Birgit S. Jacobs, Danielle H. M. van Elst-Laurijsen, Clara T. M. M. de Kanter, Erik van Maarseveen, Corrien P. W. G. M. Verwey-van Wissen, Andy I. M. Hoepelman

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	86-88
Number of pages	4
Journal	International Journal of Antimicrobial Agents
Volume	44
Issue number	1
DOIs	https://doi.org/10.1016/j.ijantimicag.2014.04.004
Publication status	Published - Jul 2014

Keywords

Anticonvulsants
Antiviral Agents
Atazanavir Sulfate
Carbamazepine
Cytochrome P-450 CYP3A
Drug Dosage Calculations
Drug Interactions
Drug Monitoring
Enzyme Activation
Epilepsy
HIV Infections
Hepatitis C
Humans
Male
Middle Aged
Oligopeptides
Pyridines
Ritonavir
Treatment Outcome

Access to Document

10.1016/j.ijantimicag.2014.04.004

Cite this

Burger, D. M., Arends, J. E., Jacobs, B. S., van Elst-Laurijsen, D. H. M., de Kanter, C. T. M. M., van Maarseveen, E., Verwey-van Wissen, C. P. W. G. M., & Hoepelman, A. I. M. (2014). Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A 'tour de force' for clinical pharmacologists. International Journal of Antimicrobial Agents, 44(1), 86-88. https://doi.org/10.1016/j.ijantimicag.2014.04.004

@article{0d6ced3709664433ab933247a901457a,

title = "Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A 'tour de force' for clinical pharmacologists",

keywords = "Anticonvulsants, Antiviral Agents, Atazanavir Sulfate, Carbamazepine, Cytochrome P-450 CYP3A, Drug Dosage Calculations, Drug Interactions, Drug Monitoring, Enzyme Activation, Epilepsy, HIV Infections, Hepatitis C, Humans, Male, Middle Aged, Oligopeptides, Pyridines, Ritonavir, Treatment Outcome",

author = "Burger, {David M.} and Arends, {Joop E.} and Jacobs, {Birgit S.} and {van Elst-Laurijsen}, {Danielle H. M.} and {de Kanter}, {Clara T. M. M.} and {van Maarseveen}, Erik and {Verwey-van Wissen}, {Corrien P. W. G. M.} and Hoepelman, {Andy I. M.}",

year = "2014",

month = jul,

doi = "10.1016/j.ijantimicag.2014.04.004",

language = "English",

volume = "44",

pages = "86--88",

journal = "International Journal of Antimicrobial Agents",

issn = "0924-8579",

publisher = "Elsevier",

number = "1",

}

Burger, DM, Arends, JE, Jacobs, BS, van Elst-Laurijsen, DHM, de Kanter, CTMM, van Maarseveen, E, Verwey-van Wissen, CPWGM & Hoepelman, AIM 2014, 'Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A 'tour de force' for clinical pharmacologists', International Journal of Antimicrobial Agents, vol. 44, no. 1, pp. 86-88. https://doi.org/10.1016/j.ijantimicag.2014.04.004

Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A 'tour de force' for clinical pharmacologists. / Burger, David M.; Arends, Joop E.; Jacobs, Birgit S. et al.
In: International Journal of Antimicrobial Agents, Vol. 44, No. 1, 07.2014, p. 86-88.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine

T2 - A 'tour de force' for clinical pharmacologists

AU - Burger, David M.

AU - Arends, Joop E.

AU - Jacobs, Birgit S.

AU - van Elst-Laurijsen, Danielle H. M.

AU - de Kanter, Clara T. M. M.

AU - van Maarseveen, Erik

AU - Verwey-van Wissen, Corrien P. W. G. M.

AU - Hoepelman, Andy I. M.

PY - 2014/7

Y1 - 2014/7

KW - Anticonvulsants

KW - Antiviral Agents

KW - Atazanavir Sulfate

KW - Carbamazepine

KW - Cytochrome P-450 CYP3A

KW - Drug Dosage Calculations

KW - Drug Interactions

KW - Drug Monitoring

KW - Enzyme Activation

KW - Epilepsy

KW - HIV Infections

KW - Hepatitis C

KW - Humans

KW - Male

KW - Middle Aged

KW - Oligopeptides

KW - Pyridines

KW - Ritonavir

KW - Treatment Outcome

U2 - 10.1016/j.ijantimicag.2014.04.004

DO - 10.1016/j.ijantimicag.2014.04.004

M3 - Letter

C2 - 24888870

SN - 0924-8579

VL - 44

SP - 86

EP - 88

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

IS - 1

ER -

Burger DM, Arends JE, Jacobs BS, van Elst-Laurijsen DHM, de Kanter CTMM, van Maarseveen E et al. Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A 'tour de force' for clinical pharmacologists. International Journal of Antimicrobial Agents. 2014 Jul;44(1):86-88. doi: 10.1016/j.ijantimicag.2014.04.004